A patient with known COPD who presents with acute dyspnea does not necessarily have a COPD exacerbation. Heart failure, PE, pneumonia, pneumothorax, and anemia all cause dyspnea and all occur in patients with COPD. Anchoring on the known diagnosis is the most common error.
CLINICAL PRINTABLE
Coming Soon.
A one-page Dyspnea clinical reference is on the way.
1 · Dyspnea Is a Symptom, Not a Diagnosis
Dyspnea is the subjective experience of breathing discomfort — the sensation that breathing requires more effort than expected, or that breathing is inadequate. It is a symptom generated by multiple mechanisms: increased respiratory drive (from hypoxemia, hypercapnia, or acidosis), increased work of breathing (from airflow obstruction or reduced lung compliance), neuromuscular weakness, and psychological factors.
The same sensation can arise from cardiac, pulmonary, hematologic, metabolic, neuromuscular, and psychiatric causes — and these causes frequently coexist. A patient with heart failure and COPD who presents with acute dyspnea may have exacerbation of either condition, both, or a third process (PE, pneumonia, pneumothorax) superimposed on both.
The clinical task is not to confirm the most likely diagnosis — it is to systematically exclude the most dangerous diagnoses and identify the treatable cause. This requires resisting the pull toward the familiar diagnosis and maintaining a broad differential until the evidence supports narrowing it.
2 · The Differential — Organized by System
Cardiac causes: acute coronary syndrome, acute decompensated heart failure, cardiac tamponade, arrhythmia (particularly atrial fibrillation with rapid ventricular response), hypertensive urgency/emergency, and valvular disease.
Pulmonary causes: pulmonary embolism, pneumothorax (spontaneous or tension), pneumonia, COPD or asthma exacerbation, pleural effusion, pulmonary hypertension, and ARDS.
Hematologic causes: severe anemia (any cause), methemoglobinemia, and carbon monoxide poisoning.
Metabolic causes: metabolic acidosis (diabetic ketoacidosis, lactic acidosis, renal failure) — the respiratory system compensates for metabolic acidosis by increasing minute ventilation, producing dyspnea without primary pulmonary or cardiac disease.
Neuromuscular causes: Guillain-Barré syndrome, myasthenia gravis, ALS, phrenic nerve injury, and diaphragmatic dysfunction.
Psychiatric causes: panic disorder, anxiety, and hyperventilation syndrome — but these are diagnoses of exclusion in the acute setting.
3 · The History — What to Ask and Why
Onset and tempo: sudden onset (seconds to minutes) suggests pneumothorax, PE, or arrhythmia. Gradual onset over hours to days suggests heart failure, pneumonia, or COPD exacerbation. Onset over weeks to months suggests anemia, malignancy, or slowly progressive cardiac or pulmonary disease.
Positional changes: orthopnea (dyspnea when lying flat) and paroxysmal nocturnal dyspnea suggest heart failure. Platypnea (dyspnea when upright, relieved by lying down) is rare but suggests hepatopulmonary syndrome or intracardiac shunt.
Associated symptoms: chest pain (ACS, PE, pneumothorax, pleuritis), fever and productive cough (pneumonia), leg swelling and asymmetric leg pain (DVT/PE), palpitations (arrhythmia), wheezing (asthma, COPD, cardiac asthma), hemoptysis (PE, malignancy, TB), and weight loss (malignancy, heart failure).
Exposures and context: recent immobility, surgery, or travel (PE); smoking history (COPD, malignancy); occupational exposures (interstitial lung disease); medications (beta-blockers worsening asthma, ACE inhibitor cough, amiodarone pulmonary toxicity); and recent allergen exposure (anaphylaxis).
4 · The Physical Exam — Mechanism-Specific Clues
Vital signs first: tachycardia (PE, arrhythmia, sepsis, anemia), hypotension (tension pneumothorax, tamponade, massive PE, cardiogenic shock), fever (pneumonia, sepsis), and respiratory rate (the most sensitive vital sign for respiratory distress — a rate above 20 is significant).
Lung exam: wheezing suggests airflow obstruction (asthma, COPD, bronchospasm) but can also occur in cardiac asthma from pulmonary edema. Crackles suggest alveolar filling (pulmonary edema, pneumonia, fibrosis) but may be absent in early or mild disease. Absent breath sounds suggest pneumothorax, pleural effusion, or consolidation. Dullness to percussion suggests effusion or consolidation; hyperresonance suggests pneumothorax.
Cardiac exam: JVD suggests elevated right-sided pressures (heart failure, PE, tamponade). S3 gallop suggests heart failure. Muffled heart sounds with JVD and hypotension suggest tamponade (Beck's triad). New murmur may indicate valvular disease or acute MR from papillary muscle rupture.
Extremities: unilateral leg swelling, warmth, and tenderness suggest DVT. Bilateral pitting edema suggests heart failure or hypoalbuminemia. Clubbing suggests chronic hypoxemia (ILD, cyanotic heart disease, lung cancer).
No single finding is pathognomonic. The physical exam provides mechanism-specific clues that, combined with the history and targeted testing, narrow the differential.
5 · Targeted Testing — Using Biomarkers and Imaging Appropriately
BNP and NT-proBNP are elevated in heart failure but also in PE, pulmonary hypertension, cor pulmonale, renal failure, and sepsis. A very high BNP (above 400 pg/mL) increases the probability of heart failure in a dyspneic patient, but a high BNP in a patient with known COPD and cor pulmonale does not diagnose new heart failure. A very low BNP (below 100 pg/mL) has a high negative predictive value for heart failure in the appropriate clinical context.
Troponin is elevated in ACS but also in PE, myocarditis, demand ischemia, and critical illness. An elevated troponin in a dyspneic patient requires interpretation in the clinical context — not automatic catheterization.
D-dimer has a high negative predictive value for PE when the pretest probability is low. A negative D-dimer in a low-probability patient effectively excludes PE. A positive D-dimer in a high-probability patient adds little — imaging is needed regardless.
Chest X-ray provides rapid assessment of pneumothorax, pleural effusion, consolidation, pulmonary edema, and cardiomegaly. It is a first-line test in most dyspneic patients but has significant limitations — a normal CXR does not exclude PE, early pneumonia, or early heart failure.
Point-of-care ultrasound (POCUS) has transformed the bedside evaluation of dyspnea. Lung ultrasound can identify B-lines (pulmonary edema), consolidation, pleural effusion, and pneumothorax. Cardiac ultrasound can assess LV function, pericardial effusion, and right heart strain. POCUS findings should be integrated with the clinical picture — not interpreted in isolation.
Apply It · Patient Scenario
A 68-year-old woman with known heart failure (EF 35%) and COPD presents with 3 days of worsening dyspnea and 2-pillow orthopnea. She has bilateral crackles on exam, mild JVD, and 2+ pitting edema. BNP is 1,840 pg/mL. She was treated for a COPD exacerbation 6 weeks ago with steroids and antibiotics.
What is the most important next step in her evaluation?
A. Treat for COPD exacerbation — she was recently treated for one and the pattern is consistent
B. Treat for acute decompensated heart failure — BNP is markedly elevated and exam findings support it
C. Obtain chest X-ray, ECG, troponin, and CBC before committing to a diagnosis — both conditions are present and a third process must be excluded
D. Check D-dimer — PE is the most dangerous diagnosis to exclude first
ANSWER
C. Obtain chest X-ray, ECG, troponin, and CBC before committing to a diagnosis — both conditions are present and a third process must be excluded.
RATIONALE
The clinical picture is most consistent with acute decompensated heart failure — orthopnea, bilateral crackles, JVD, edema, and markedly elevated BNP. However, this patient has both heart failure and COPD, and the two conditions can coexist in the same exacerbation. More importantly, a third process must be excluded before committing to treatment.
Chest X-ray will assess for pulmonary edema, consolidation (pneumonia), and pleural effusion. ECG will assess for new arrhythmia or ischemia. Troponin will assess for ACS as a precipitant of decompensation. CBC will assess for anemia (which can precipitate heart failure decompensation and cause dyspnea independently). These tests take minutes and significantly narrow the differential before treatment is initiated.
The BNP of 1,840 pg/mL strongly supports heart failure as the primary driver — but BNP is also elevated in PE and cor pulmonale. If the CXR and clinical picture are consistent with heart failure, treatment can begin while awaiting other results. The key is not to anchor on heart failure and miss a concurrent ACS, pneumonia, or PE.
Clinical Pearl: In a patient with multiple chronic conditions, acute dyspnea may represent exacerbation of any one of them, all of them, or a new process superimposed on all of them. The prior diagnoses explain the baseline — not the acute change.
NOW CHANGE ONE DETAIL
Same patient. Same presentation. Now troponin is elevated at 0.8 ng/mL (high sensitivity) and ECG shows new ST depression in leads V4–V6.
UPDATED REASONING
New ST depression and elevated troponin in the context of acute dyspnea and heart failure decompensation raises concern for ACS as the precipitant. This changes the management significantly — cardiology should be involved immediately, and the decision about anticoagulation, antiplatelet therapy, and potential catheterization must be made in the context of her heart failure and COPD.
The heart failure treatment (diuresis) remains appropriate, but the underlying cause — possible ACS — must be addressed. This is the clinical demonstration of why a systematic evaluation is essential before committing to a single diagnosis in a dyspneic patient with multiple comorbidities.
Understand It · The Nuance
The most common error in dyspnea evaluation is anchoring on the most familiar diagnosis and failing to consider competing causes. The second most common error is treating biomarkers as organ-specific when they are not.
Dyspnea is a symptom, not a diagnosis — and it has many causes
Dyspnea is the subjective experience of breathing discomfort. It is a symptom generated by multiple mechanisms: increased respiratory drive (hypoxemia, hypercapnia, acidosis), increased work of breathing (airflow obstruction, reduced compliance), neuromuscular weakness, and psychological factors. The same sensation can arise from cardiac, pulmonary, hematologic, metabolic, neuromuscular, and psychiatric causes — often in combination.
Anchoring on one system is the most common diagnostic error
A patient with known COPD who presents with dyspnea does not necessarily have a COPD exacerbation. Heart failure, pulmonary embolism, pneumonia, pneumothorax, and anemia all cause dyspnea and all occur in patients with COPD. The prior diagnosis explains the baseline — it does not explain the acute change. Anchoring on the known diagnosis and failing to consider competing causes is a leading cause of missed diagnoses in dyspneic patients.
BNP and troponin are not cardiac-specific in the context of dyspnea
BNP is elevated in heart failure but also in pulmonary embolism, pulmonary hypertension, cor pulmonale, renal failure, and sepsis. Troponin is elevated in ACS but also in PE, myocarditis, demand ischemia, and critical illness. These biomarkers add information — they do not replace clinical assessment. A high BNP in a dyspneic patient with known COPD and cor pulmonale does not diagnose new heart failure.
The physical exam provides mechanism-specific clues
Wheezing suggests airflow obstruction (asthma, COPD, bronchospasm) but can also occur in cardiac asthma from pulmonary edema. Crackles suggest alveolar filling (pulmonary edema, pneumonia, fibrosis) but may be absent in early or mild disease. Absent breath sounds suggest pneumothorax, pleural effusion, or consolidation. JVD, S3 gallop, and peripheral edema point toward heart failure. Unilateral leg swelling with dyspnea raises concern for PE. No single finding is pathognomonic.
Anxiety and panic disorder are diagnoses of exclusion in acute dyspnea
Anxiety and panic disorder cause genuine dyspnea through hyperventilation and increased respiratory drive. However, they are diagnoses of exclusion in the acute setting — PE, ACS, pneumothorax, and other life-threatening causes must be excluded before attributing acute dyspnea to anxiety. A patient with known anxiety who presents with acute dyspnea deserves the same systematic evaluation as any other patient.
Clinical Pearl: Metabolic acidosis (DKA, lactic acidosis, renal failure) causes dyspnea through compensatory hyperventilation — the respiratory system is responding to the metabolic problem. Always check a basic metabolic panel in unexplained dyspnea.
Bottom Line
Maintain a broad differential. The prior diagnosis explains the baseline — not the acute change. Use the history, exam, and targeted testing systematically before committing to a single cause.
Dyspnea has cardiac, pulmonary, hematologic, metabolic, neuromuscular, and psychiatric causes — often in combination.
Anchoring on a known diagnosis (COPD, heart failure) is the most common error — the prior diagnosis explains the baseline, not the acute change.
BNP and troponin add information but are not organ-specific in the context of dyspnea — interpret in clinical context.
Metabolic acidosis causes dyspnea through compensatory hyperventilation — always check a basic metabolic panel.
Anxiety and panic disorder are diagnoses of exclusion in acute dyspnea — life-threatening causes must be excluded first.
The physical exam provides mechanism-specific clues — use it systematically before ordering tests.
In a patient with multiple chronic conditions, the acute change may represent exacerbation of any one, all, or a new process superimposed on all of them.
EVIDENCE & REFERENCES
- Parshall MB, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435–452. doi:10.1164/rccm.201111-2042ST
- Berliner D, et al. The differential diagnosis of dyspnea. Dtsch Arztebl Int. 2016;113(49):834–845. doi:10.3238/arztebl.2016.0834